Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES

(GILD)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Latest news on GILEAD SCIENCES
2017Investors in big pharma, biotech look to ride out Trump storm
RE
2017GILEAD SCIENCES : European Commission Grants Marketing Authorization for Gilead'..
BU
2017GILEAD SCIENCES : Awards More Than $22 Million in Grants to Support HIV Cure Res..
BU
2017Pennsylvania Is Ordered to Provide Hepatitis C Drug to Inmate--Update
DJ
2017Pennsylvania Is Ordered to Provide Hepatitis C Drug to Inmate
DJ
2017GILEAD SCIENCES : Alessandro Riva, MD, to Join Gilead as Senior Vice President, ..
BU
2016GILEAD SCIENCES : to Present at the 35th Annual J.P. Morgan Healthcare Conferenc..
BU
2016GILEAD SCIENCES : Japan's Ministry of Health, Labour and Welfare Approves Gilead..
BU
2016LOCKHEED MARTIN : Business Watch -- WSJ
DJ
2016GILEAD SCIENCES : Ordered to Pay $2.5 Billion in Damages to Merck & Co. -- Updat..
DJ
2016GILEAD SCIENCES : Ordered to Pay $2.5 Billion in Damages to Merck & Co.
DJ
2016GILEAD SCIENCES : Court Orders Gilead to Pay Merck $2.54 Billion in Patent Case ..
DJ
2016GILEAD SCIENCES, INC. : Ex-dividend day for
FA
2016GILEAD SCIENCES : Submits New Drug Application to U.S. Food and Drug Administrat..
BU
2016GILEAD SCIENCES : Announces Promotion of James R. Meyers to Executive Vice Presi..
BU
2016GILEAD SCIENCES : Announces Top-Line Results From Two Phase 3 Studies Evaluating..
BU
2016GILEAD SCIENCES : to Present at the Annual Piper Jaffray Healthcare Conference o..
BU
2016GILEAD SCIENCES : Phase 2 Data for Selonsertib in Nonalcoholic Steatohepatitis (..
BU
2016Medicare Identifies Which Prescription Drugs Were Costliest in 2015
DJ
2016GILEAD SCIENCES : European CHMP Adopts Positive Opinion for Gilead's Vemlidy® (T..
BU
2016GILEAD SCIENCES : U.S. Food and Drug Administration Approves Gilead's Vemlidy® (..
BU
2016GILEAD SCIENCES : J&J vaccine plus Gilead immune booster shows promise as HIV fi..
RE
2016Pharma Stocks Gain on U.S. Election Result
DJ
2016U.S. HOT STOCKS : Hot Stocks to Watch
DJ
2016Gilead Sales of Hepatitis C Drugs Harvoni and Sovaldi Slump
DJ
2016GILEAD SCIENCES : Sales of Hepatitis C Drugs Harvoni and Sovaldi Slump Under Com..
DJ
2016GILEAD SCIENCES : Announces Fourth Quarter 2016 Dividend
BU
2016GILEAD SCIENCES : Announces Third Quarter 2016 Financial Results
BU
2016GILEAD SCIENCES : to Release Third Quarter 2016 Financial Results on Tuesday, No..
BU
2016MERCK : Profit Rises on Cancer Drugs, Vaccines
DJ
2016GILEAD SCIENCES : to Present at the Credit Suisse 25th Annual Healthcare Confere..
BU
2016GILEAD SCIENCES : Presents Results from Phase 3 Studies Evaluating Switching to ..
BU
2016GILEAD SCIENCES : Announces SVR12 Rates From Four Phase 3 Studies of a Once-Dail..
BU
2016GILEAD SCIENCES : Announces Top-Line Phase 2 Results for GS-4997 (Selonsertib) i..
BU
2016Singapore's Temasek Hires Veteran Goldman Banker
DJ
2016FDA Warns on Hepatitis C Drugs
DJ
2016GILEAD SCIENCES : and the World Health Organization Announce Five-Year Visceral ..
BU
2016GILEAD SCIENCES : Terminates Phase 2/3 Study of GS-5745 in Patients With Ulcerat..
BU
2016GILEAD SCIENCES : Halts Test of Bowel Disease Treatment
DJ
2016Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal
DJ
2016GILEAD SCIENCES : Prices $5 Billion of Senior Unsecured Notes
BU
2016GILEAD SCIENCES, INC. : Ex-dividend day for
FA
2016GILEAD SCIENCES : Scientists Honored for Hep C Research
DJ
2016GILEAD SCIENCES : to Present at Three Upcoming Investor Conferences in September
BU
2016Mylan Faces Scrutiny Over EpiPen Price Increases
DJ
2016GILEAD SCIENCES : Kelly A. Kramer Joins Gilead Sciences' Board of Directors
BU
2016Deal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
DJ
2016Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
DJ
2016GILEAD SCIENCES : European Commission Grants Marketing Authorization for Gilead'..
BU
2016Merck Revenue Rises on Cancer, Hepatitis Treatments
DJ
2016MERCK : Revenue Rises on Cancer, Hepatitis Treatments
DJ
2016GILEAD SCIENCES : cuts 2016 sales forecast, cites hepatitis C drugs
RE
2016GILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- 2nd Update
DJ
2016GILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- 3rd Update
DJ
2016GILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- Update
DJ
2016GILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19%
DJ
2016GILEAD SCIENCES : Announces Third Quarter 2016 Dividend
BU
2016GILEAD SCIENCES : Announces Second Quarter 2016 Financial Results
BU
2016Gilead Sales of Hepatitis C Drugs Fall 19%
DJ
2016GILEAD SCIENCES : European CHMP Adopts Positive Opinion on Gilead's Type II Vari..
BU
2016GILEAD SCIENCES : Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) M..
BU
2016GILEAD SCIENCES : to Release Second Quarter 2016 Financial Results on Monday, Ju..
BU
2016GILEAD SCIENCES : European Commission Grants Marketing Authorization for Gilead'..
BU
2016GILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
DJ
2016GILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
DJ
2016GILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
DJ
2016GILEAD SCIENCES : U.S. Food and Drug Administration Approves Gilead's Epclusa® (..
BU
2016GILEAD SCIENCES : European Commission Grants Marketing Authorization for Gilead'..
BU
2016S&P 500 Firms Spent $161.4 Billion on First-Quarter Share Buybacks
DJ
2016GILEAD SCIENCES : Presents Preliminary Data on Bictegravir, an Investigational I..
BU
2016GILEAD SCIENCES, INC. : Ex-dividend day for
FA
2016GILEAD SCIENCES : to Present at the 36th Annual William Blair Growth Stock Confe..
BU
2016GILEAD SCIENCES : to Present at the Jefferies 2016 Healthcare Conference on Frid..
BU
2016Judge Sides With Gilead in Drug-Patent Dispute -- WSJ
DJ
2016GILEAD SCIENCES : to Present at the Goldman Sachs 37th Annual Global Healthcare ..
BU
Prev.3  4  5  6  7   8  9  10  11  12Next
Official Publications
07/01Report 
06/20Report 
05/29Nomination 
05/29SEC Filing 8K 
05/10Report 
05/08Report 
Upcoming event on GILEAD SCIENCES